Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Early Low Rectal Cancer × spartalizumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 18 Carcinoma, Hepatocellular 18 Pancreatic Neoplasms 14 Stomach Neoplasms 10 Rectal Neoplasms 8 Neoplasm Metastasis 7 Locally Advanced Rectal Cancer 7 Esophageal Neoplasms 7 Triple Negative Breast Neoplasms 5 Liver Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 4 Lung Neoplasms 4 Gastrointestinal Stromal Tumors 4 Esophageal Squamous Cell Carcinoma 4 Endometrial Neoplasms 4 Colonic Neoplasms 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Sarcoma 3 Ovarian Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Lymphoma 2 Digestive System Neoplasms 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2

Interventions

toripalimab 2 Oxaliplatin 2 Capecitabine 2 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05555888 2025-01-15

TORCH-E

Fudan University

Phase 2 Recruiting

Gastrointestinal

Early Low Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡